A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19

D Zhang, D Kukkar, KH Kim, P Bhatt - International Journal of Biological …, 2024 - Elsevier
Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …

Immunouniverse of SARS-CoV-2

D Jiménez, M Torres Arias - Immunological Medicine, 2022 - Taylor & Francis
SARS-CoV-2 virus has become a global health problem that has caused millions of deaths
worldwide. The infection can present with multiple clinical features ranging from …

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation

JT Sandberg, R Varnaitė, W Christ… - Clinical & …, 2021 - Wiley Online Library
Objectives Humoral and cellular immunity to SARS‐CoV‐2 following COVID‐19 will likely
contribute to protection from reinfection or severe disease. It is therefore important to …

[HTML][HTML] SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study

CA Prete Jr, LF Buss, C Whittaker, T Salomon… - Elife, 2022 - elifesciences.org
Background: The COVID-19 situation in Brazil is complex due to large differences in the
shape and size of regional epidemics. Understanding these patterns is crucial to understand …

COVID-19 vaccination immune paresis in heart and lung transplantation

S Aslam, L Danziger-Isakov, MR Mehra - The Journal of Heart and …, 2021 - jhltonline.org
Vaccines against symptomatic coronavirus disease-19 (COVID-19) demonstrate marked
efficacy within clinical trials of immunocompetent persons with significant reduction in severe …

[HTML][HTML] Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust

H Colton, D Hodgson, H Hornsby, R Brown… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
Background: We aimed to measure SARS-CoV-2 seroprevalence in a cohort of healthcare
workers (HCWs) during the first UK wave of the COVID-19 pandemic, explore risk factors …

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients–implications for the omicron variant

Y Peled, A Afek, Y Kreiss, G Rahav, I Nemet… - The Journal of Heart and …, 2022 - Elsevier
Background The durability of the immune response following the 3-dose BNT162b2
vaccination is unknown. The complexity of the situation is enhanced by the threat that highly …

[HTML][HTML] Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021

A Drouin, ID Plumb, M McCullough, J James Gist… - Scientific Reports, 2024 - nature.com
Louisiana experienced high morbidity and mortality from COVID-19. To assess possible
explanatory factors, we conducted a cohort study (ClinSeqSer) of patients hospitalized with …

[HTML][HTML] SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An …

E Parker, J Thomas, KJ Roper, S Ijaz… - Frontiers in …, 2023 - frontiersin.org
The SARS-CoV-2 pandemic enables the analysis of immune responses induced against a
novel coronavirus infecting immunologically naïve individuals. This provides an opportunity …

[HTML][HTML] Cord blood SARS-CoV-2 IgG antibodies and their association with maternal immunity and neonatal outcomes

AC Helguera-Repetto, I Villegas-Mota… - Frontiers in …, 2022 - frontiersin.org
Passive transplacental immunity is crucial for neonatal protection from infections. Data on
the correlation between neonatal immunity to SARS-CoV-2 and protection from adverse …